Vaiarelli Alberto, Cimadomo Danilo, Rucci Cecilia, Innocenti Federica, Taggi Marilena, Pittana Erika, Fiorentino Giulia, Petrone Pasquale, Soscia Daria Maria, Fabozzi Gemma, Mazzilli Rossella, Rienzi Laura, Ubaldi Filippo Maria, Nappi Rossella Elena, Gennarelli Gianluca
IVIRMA Global Research Alliance, Genera, Clinica Valle Giulia, Via G. De Notaris 2B, Rome, Italy.
Department of Surgical Sciences, Gynecologic Unit, University of Rome Tor Vergata, Rome, Italy.
J Assist Reprod Genet. 2024 Dec;41(12):3423-3432. doi: 10.1007/s10815-024-03299-z. Epub 2024 Nov 4.
To assess oocyte competence and embryo chromosomal constitution in phenotype-D PCOS women undergoing ICSI for PGT-A at the blastocyst stage.
Retrospective study at a private IVF center. In the period 2013-2021, 58 naïve phenotype-D PCOS women (i.e., oligomenorrhea, ovarian PCO-morphology, and absence of hyperandrogenism) underwent ICSI with ejaculated sperm for PGT-A. These cases were matched to 58 controls selected from 2211 naïve women with idiopathic infertility planned for the same treatment in the same period. The matching variables were age (≈ 36 years), BMI (≈ 22), cumulus oocyte complexes (COCs) retrieved (≈ 21-23), and sperm quality (≈ 43-45% men with all sperm parameters > 5th percentile). The primary outcome was euploid blastocyst rate (EBR) per cohort of inseminated oocytes.
Maturation rates per COCs and euploidy per biopsied blastocysts were similar. PCOS patients with phenotype-D showed higher fertilization per inseminated oocytes and higher blastulation per zygotes. This resulted into a higher EBR per inseminated oocytes and more euploid blastocysts available for transfer, although these differences adjusted for confounders were not significant. The live birth rate per first euploid transfers was comparable, so were all other outcomes considered.
Oocyte competence was not compromised in phenotype-D PCOS women, while good prognosis idiopathic infertile women might have unknown oocyte issues. In case of repeated failures after intrauterine insemination, a timely referral to IVF might represent an efficient strategy, in line with the "one-and-done" approach fulfilling a family planning perspective. Indeed, 22% of the phenotype-D PCOS women had 2 singleton LBs and 76% had surplus oocytes/euploid blastocysts after achieving ≥ 1 live birth.
评估在囊胚期接受植入前遗传学检测非整倍体(PGT-A)的卵胞浆内单精子注射(ICSI)的D型多囊卵巢综合征(PCOS)女性的卵母细胞质量和胚胎染色体组成。
在一家私立体外受精(IVF)中心进行回顾性研究。在2013年至2021年期间,58例初发性D型PCOS女性(即月经稀发、卵巢多囊样形态且无高雄激素血症)接受了经射精精子的ICSI治疗以进行PGT-A。这些病例与同期从2211例计划进行相同治疗的初发性特发性不孕女性中选出的58例对照进行匹配。匹配变量包括年龄(约36岁)、体重指数(BMI,约22)、获取的卵丘卵母细胞复合体(COC)数量(约21-23个)以及精子质量(所有精子参数>第5百分位数的男性约占43-45%)。主要结局是每个授精卵母细胞队列的整倍体囊胚率(EBR)。
每个COC的成熟率和每个活检囊胚的整倍体率相似。D型PCOS患者每个授精卵母细胞的受精率更高,每个受精卵的囊胚形成率更高。这导致每个授精卵母细胞的EBR更高,并且有更多可用于移植的整倍体囊胚,尽管在对混杂因素进行调整后这些差异并不显著。首次整倍体移植后的活产率相当,所考虑的所有其他结局也是如此。
D型PCOS女性的卵母细胞质量未受损害,而预后良好的特发性不孕女性可能存在未知的卵母细胞问题。在宫内人工授精反复失败的情况下,及时转诊至IVF可能是一种有效的策略,符合从计划生育角度出发的“一次成功”方法。事实上,22%的D型PCOS女性有2次单胎活产,76%在实现≥1次活产后有多余的卵母细胞/整倍体囊胚。